Uhlmann Price Securities, LLC Bristol Myers Squibb CO Transaction History
Uhlmann Price Securities, LLC
- $164 Billion
- Q3 2025
A detailed history of Uhlmann Price Securities, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Uhlmann Price Securities, LLC holds 5,428 shares of BMY stock, worth $254,084. This represents 0.15% of its overall portfolio holdings.
Number of Shares
5,428
Previous 6,151
11.75%
Holding current value
$254,084
Previous $285 Million
14.03%
% of portfolio
0.15%
Previous 0.2%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,692Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...